Tectonic Therapeutic (TECX) EPS (Weighted Average and Diluted) (2021 - 2026)
Tectonic Therapeutic (TECX) reported EPS (Weighted Average and Diluted) of -$1.34 for Q1 2026, down 44.09% year-over-year from -$2.4 in Q1 2025, and down 30.1% quarter-over-quarter from -$1.03 in Q4 2025.
Tectonic Therapeutic (TECX) EPS (Weighted Average and Diluted) (2021 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 6 years of EPS (Weighted Average and Diluted) data on file, last reported at -$1.34 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$1.34, down 44.09% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.46 (up 27.36% YoY), and the FY2025 annual result was -$4.05, up 40.7% from the prior year.
- EPS (Weighted Average and Diluted) declined to -$1.34 in Q1 2026 per TECX's latest filing, from -$1.03 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $0.33 in Q4 2024 and troughed at -$10.97 in Q1 2024.
- A 5-year average of -$2.73 and a median of -$1.03 in 2025 frame the typical range for EPS (Weighted Average and Diluted).
- On a YoY basis, EPS (Weighted Average and Diluted) climbed as much as 105.79% in 2024 and fell as far as 1824.56% in 2024.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.57 in 2022, then tumbled by 900.0% to -$5.7 in 2023, then jumped by 105.79% to $0.33 in 2024, then slumped by 412.12% to -$1.03 in 2025, then sank by 30.1% to -$1.34 in 2026.
- Business Quant data shows TECX's EPS (Weighted Average and Diluted) at -$1.34 in Q1 2026, -$1.03 in Q4 2025, and -$1.02 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 0.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -0.61 |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | -1.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.34 |
| Dec 31, 2025 | -1.03 |
| Sep 30, 2025 | -1.02 |
| Jun 30, 2025 | -1.07 |
| Mar 31, 2025 | -0.93 |
| Dec 31, 2024 | 0.33 |
| Sep 30, 2024 | -1.20 |
| Jun 30, 2024 | -4.34 |
| Mar 31, 2024 | -10.97 |
| Dec 31, 2023 | -5.70 |
| Sep 30, 2023 | -7.62 |
| Jun 30, 2023 | -8.51 |
| Mar 31, 2023 | -0.57 |
| Dec 31, 2022 | -0.57 |
| Sep 30, 2022 | -0.52 |
| Jun 30, 2022 | -0.64 |
| Mar 31, 2022 | -0.68 |
| Dec 31, 2021 | -0.65 |
| Sep 30, 2021 | -0.75 |
| Jun 30, 2021 | -0.74 |